UDG Healthcare Public Limited Co. Directorate Change (8169K)
26 September 2016 - 8:10PM
UK Regulatory
TIDMUDG
RNS Number : 8169K
UDG Healthcare Public Limited Co.
26 September 2016
UDG Healthcare PLC
26 September 2016
Directorate Change
UDG Healthcare plc ("the Group"), a leading international
provider of healthcare services, announces that Chris Corbin, CEO
of Ashfield Commercial & Medical Services, has advised of his
intention to retire from the Group in April 2019. In preparation
for his retirement, Chris will transition to the role of Chairman
of Ashfield once his successor has been appointed. This will
facilitate a phased transition of Chris's responsibilities over the
next two and half years. In addition, Chris will remain as a member
of the Board of Directors of UDG Healthcare until his
retirement.
Brendan McAtamney, CEO of UDG Healthcare, said: "I would like to
thank Chris for his substantial contribution to the success of both
the Group and Ashfield since joining us in 2000. Under his
leadership, Ashfield has developed into a leading international
healthcare services organisation and a key division of the Group.
We will work closely with Chris over the next two and a half years
to ensure a professional transition process and thereafter wish him
the very best in retirement".
For further information, please contact:
Investors and Analysts:
Alan Ralph Keith Byrne
CFO Head of Investor Relations,
UDG Healthcare plc Strategy & Corporate Communications
Tel: +353-1-468-9000 UDG Healthcare plc
Tel: + 353-1-468-9000
About UDG Healthcare plc:
UDG Healthcare plc (LON: UDG) is a leading international partner
of choice delivering clinical, commercial, communication and
packaging services to the healthcare industry, employing over 7,000
employees at operations across 20 countries including the US, UK,
Ireland and Germany.
UDG Healthcare plc operates across three divisions: Ashfield
Commercial & Medical Services, Sharp Packaging Services and
Aquilant Specialist Healthcare Services.
Ashfield Commercial & Medical Services is a global leader in
commercialisation services for the pharmaceutical and healthcare
industry, operating across two broad areas of activity: commercial
and clinical services, and healthcare communications. It focuses on
supporting healthcare professionals and patients at all stages of
the product life cycle. The division provides sales teams,
healthcare communications, telesales, nurse educators, medical
information, pharmacovigilance (drug safety), regulatory and event
management services to over 300 healthcare companies in 18
countries.
Sharp Packaging Services is a global leader in contract
packaging and clinical trial packaging services for the
pharmaceutical and biotechnology industries, operating from state
of the art facilities across the US and Europe. Sharp is also a
world leader in 'Track and Trace' serialisation services, which
will require all prescription drugs to have a unique serial code
for authentication and traceability.
Aquilant Specialist Healthcare Services is a leading provider of
outsourced sales, marketing, distribution and engineering services
to the medical and scientific sectors in the UK, Ireland and the
Netherlands.
The company is listed on the London Stock Exchange and is a
constituent of the FTSE 250.
For more information, please go to: www.udghealthcare.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
BOABGGDCXGDBGLL
(END) Dow Jones Newswires
September 26, 2016 06:10 ET (10:10 GMT)
Udg Healthcare Public (LSE:UDG)
Historical Stock Chart
From Apr 2024 to May 2024
Udg Healthcare Public (LSE:UDG)
Historical Stock Chart
From May 2023 to May 2024